With No Open Access Deal, UC Breaks with Elsevier

After negotiating for eight months, the University of California becomes one of the first research institutions in the US to stop paying for access to the publisher’s journals.

Written byCarolyn Wilke
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: UC Berkeley
© ISTOCK.COM, NOTHJC

The University of California has ended its subscription to journals published by Elsevier, citing a failure to reach an agreement that would lower fees and prioritize open access to its scholars’ work, the UC system announced yesterday (February 28). The decision to stop paying for access to Elsevier’s journals came after eight months of contract negotiations.

The university system’s previous contract with the publishing giant expired on December 31, and the research heavyweight, accounting for nearly 10 percent of research output in the US, aimed to secure a deal to pay a one-time fee that covered both journal subscriptions and the processing fees to make UC researchers’ articles open access for all readers.

The break with Elsevier is part of UC’s push for free access to publicly funded research. “I fully support our faculty, staff and students in breaking down paywalls that hinder the sharing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies